EphB6 expression was discovered to be lower in colorectal cancers in contrast to adenoma and healthy tissues, and its loss promotes tumour progression, since EphB6 knockdown elevated lung metastasis in mice, whereas reintroducing EphB6 into colon cancer cells substantially lowered metastases [99,100]. Here, EPHB6 is linked to colonic neoplasm.